Timothy Keutzer's Insider Trades & SAST Disclosures
Timothy Keutzer's most recent trade in Spero Therapeutics Inc was a trade of 266,139 Common Stock done . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Timothy Keutzer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spero Therapeutics Inc | Timothy Keutzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 266,139 | 797,976 (4%) | 1% | 0 | Common Stock | |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 27,643 | 766,359 (3%) | 0% | 0.8 | 21,562 | Common Stock |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 24,920 | 741,439 (3%) | 0% | 0.8 | 19,438 | Common Stock |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 3,974 | 794,002 (4%) | 0% | 0.8 | 3,100 | Common Stock |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 27 Aug 2024 | 2,213 | 531,837 (2%) | 0% | 1.4 | 2,988 | Common Stock |
| Spero Therapeutics Inc | Keutzer Timothy | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 239,731 | 565,021 (2%) | 1% | 0 | Common Stock | |
| Spero Therapeutics Inc | Keutzer Timothy | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 01 Feb 2024 | 30,971 | 534,050 (2%) | 0% | 1.4 | 42,121 | Common Stock |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.26 per share. | 28 Aug 2023 | 1,854 | 325,290 (1%) | 0% | 1.3 | 2,336 | Common Stock |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 265,957 | 330,538 (1%) | 1% | 0 | Common Stock | |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 01 Feb 2023 | 3,394 | 327,144 (1%) | 0% | 1.9 | 6,313 | Common Stock |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 53,190 | 53,190 | - | - | Stock Option (Right to Buy) | |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 38,014 | 64,581 (0%) | 0% | 0 | Common Stock | |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 24,067 | 26,567 (0%) | 0% | 0 | Common Stock | |
| Spero Therapeutics Inc | Timothy Keutzer | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 57,432 | 57,432 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges